Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POLO-Trial. Precise Neoadjuvant Chemoresection of Low-grade NMIBC Guided by Drug Sceens in Patient-derived Or-ganoids. An Open-label, Phase II Trial.

NCT06227065 is registered in ClinicalTrials.gov with Hospital Centre Biel/Bienne as lead sponsor.

NCT NCT06227065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06227065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POLO-Trial. Precise Neoadjuvant Chemoresection of Low-grade NMIBC Guided by Drug Sceens in Patient-derived Or-ganoids. An Open-label, Phase II Trial.
Lead sponsor
Hospital Centre Biel/Bienne
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
November 30, 2031
Enrollment
28 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, low grade, non-muscle invasive bladder cancer